Andre Jacques Auberton Herve is Director of Bionik Laboratories Corp.. Currently has a direct ownership of 95,149 shares of BNKL, which is worth approximately $9,514. The most recent transaction as insider was on Mar 26, 2021, when has been sold 95,149 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.1K
0% 3M change
0% 12M change
Total Value Held $9,514

ANDRE-JACQUES AUBERTON-HERVE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2021
BUY
Open market or private purchase
-
95,149 Added 50.0%
95,149 Common Stock, par valu...

Also insider at

CLAYU
Chavant Capital Acquisition Corp. Financial Services
AA

Andre Jacques Auberton Herve

Director
Toronto, A6

Track Institutional and Insider Activities on BNKL

Follow Bionik Laboratories Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNKL shares.

Notify only if

Insider Trading

Get notified when an Bionik Laboratories Corp. insider buys or sells BNKL shares.

Notify only if

News

Receive news related to Bionik Laboratories Corp.

Track Activities on BNKL